
NovoCure Limited NVCR
$ 10.72
1.32%
Annual report 2025
added 02-26-2026
NovoCure Limited EV/EBITDA Ratio 2011-2026 | NVCR
Annual EV/EBITDA Ratio NovoCure Limited
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| -243 | 417 | 1.1 K | -176 | -64.3 | -4.73 | -2.81 | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.1 K | -243 | 146 |
EV/EBITDA Ratio of other stocks in the Health care industry
| Issuer | EV/EBITDA Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Anthem
ANTM
|
19.2 | - | -2.32 % | $ 107 B | ||
|
Cigna Corporation
CI
|
9.45 | $ 275.12 | 1.42 % | $ 72.5 B | ||
|
Triple-S Management Corporation
GTS
|
79.5 | - | 0.28 % | $ 847 M | ||
|
Magellan Health, Inc.
MGLN
|
16.1 | - | -0.19 % | $ 2.49 B | ||
|
CVS Health Corporation
CVS
|
16.2 | $ 78.09 | -1.56 % | $ 98.9 B | ||
|
Centene Corporation
CNC
|
26.4 | $ 37.47 | 0.46 % | $ 18.5 B | ||
|
Molina Healthcare
MOH
|
20.4 | $ 149.98 | 2.81 % | $ 7.92 B | ||
|
UnitedHealth Group Inc.
UNH
|
21.6 | $ 313.0 | 2.82 % | $ 284 B | ||
|
Humana
HUM
|
21.3 | $ 198.23 | 3.16 % | $ 23.9 B |